Cargando…
Inhibition of autotaxin alleviates pathological features of hepatic encephalopathy at the level of gut–liver–brain axis: an experimental and bioinformatic study
There is accumulating evidence that the circulatory levels of autotaxin (ATX) and lysophosphatidic acid (LPA) are increased in patients with severe liver disease. However, the potential role of the ATX-LPA axis in hepatic encephalopathy (HE) remains unclear. Our study aimed to investigate the role o...
Autores principales: | Sepehrinezhad, Ali, Shahbazi, Ali, Joghataei, Mohammad Taghi, Larsen, Fin Stolze, Sahab Negah, Sajad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394058/ https://www.ncbi.nlm.nih.gov/pubmed/37528089 http://dx.doi.org/10.1038/s41419-023-06022-5 |
Ejemplares similares
-
Drug-induced-acute liver failure: A critical appraisal of the thioacetamide model for the study of hepatic encephalopathy
por: Sepehrinezhad, Ali, et al.
Publicado: (2021) -
New Insight Into Mechanisms of Hepatic Encephalopathy: An Integrative Analysis Approach to Identify Molecular Markers and Therapeutic Targets
por: Sepehrinezhad, Ali, et al.
Publicado: (2023) -
Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain
por: Shahbazi, Ali, et al.
Publicado: (2023) -
The Glymphatic System May Play a Vital Role in the Pathogenesis of Hepatic Encephalopathy: A Narrative Review
por: Sepehrinezhad, Ali, et al.
Publicado: (2023) -
COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review
por: Sepehrinezhad, Ali, et al.
Publicado: (2020)